June 21, 2018
We sure hope everyone is loving the new products as much as we are here at the home office. Now that Plexus Worldwide® is focusing more on the “worldwide”, product and market launches can pose interesting challenges for Ambassadors eager to advertise to a different market. This week, we’re tackling how to properly operate Plexus businesses when new markets and products come into play.
Products sometimes have different launch windows
As we’ve discussed previously, different markets each have their own regulations, which means that you will often see unique materials available to each of those markets; this includes product claims, product formulations, and even compensation plans. These differences can affect product launch timing.
For example, the new Slim Hunger Control* was announced earlier this year and is available for all U.S. Ambassadors. However, since the product has not yet completed the registration process with Health Canada, it is not slated to be available to the Canadian market until 2019. We get it; Slim Hunger Control is amazing, but sharing it indiscriminately, or intentionally to another market before it is ready, can end up hurting you when your Canadian audience discovers they are unable to purchase.
Products sometimes have different approved claims
Another reason to think before sharing is because international products sometimes have different approved claims. For example, with Joyōme™, Plexus® was able to have a simultaneous product launch between the U.S. and Canada. And while the large majority of product claims are shared between the two markets, not all of the provided marketing claims were identical.
By automatically assuming that product claims are the same across all markets, you may be doing yourself a disservice. Downlines tend to follow in their upline’s footsteps, and starting your team off on the wrong foot means it’s that much more difficult to make corrections later.
Marketing the products in Australia
Since Plexus is not open in Australia, its products are not available for sale in that market. However, while Plexus is completing the registration process to open the new market, Australians are allowed to purchase Plexus products for personal use on a Not For Resale (NFR) basis. This means that the products cannot be advertised to that market, but Australians may purchase them for personal consumption in the interim.
While Plexus was working on Canada’s launch, this is how Canadians were able to purchase products. And now that Plexus has its eyes on Australia, this is how Australians are able to purchase products. But it also means that it is against regulations for Ambassadors to actively market the products to Australia until it is officially launched.
Marketing the opportunity in Australia
We understand the excitement that accompanies a new product launch or the promise of a new market, but a little patience can go a long way. Help us launch new products and markets the right way by taking some time to learn the differences between each market.
*This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
posted 8 months ago